These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16291423)

  • 1. Improving outcomes in the treatment of locally-advanced NSCLC with gemcitabine.
    Choy H; Vokes E
    Lung Cancer; 2005 Oct; 50 Suppl 1():S10-2. PubMed ID: 16291423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine, cisplatin, and hyperfractionated accelerated radiotherapy for locally advanced non-small cell lung cancer.
    Zwitter M; Kovac V; Smrdel U; Strojan P
    J Thorac Oncol; 2006 Sep; 1(7):662-6. PubMed ID: 17409933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Gemcitabine and radiotherapy in non-small cell lung cancer: dolce vita at last!].
    Girard N; Mornex F
    Bull Cancer; 2007; 94 Spec No Actualites():S127-33. PubMed ID: 17845982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel triplet regimen with paclitaxel, carboplatin and gemcitabine (PACCAGE) as induction chemotherapy for locally advanced unresectable non small cell lung cancer (NSCLC).
    Schallier D; Neyns B; Fontaine C; Steene JV; De Mey J; Meysman M; De Grève J
    Lung Cancer; 2007 May; 56(2):247-54. PubMed ID: 17337086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of induction chemotherapy with gemcitabine and vinorelbine followed by concurrent chemoradiotherapy with oral etoposide and cisplatin in patients with inoperable stage III non-small-cell lung cancer.
    Lee DH; Han JY; Cho KH; Pyo HR; Kim HY; Yoon SJ; Lee JS
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1037-44. PubMed ID: 16024178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent radiotherapy and gemcitabine after induction with gemcitabine and carboplatin.
    Arrieta O; Gallardo-Rincón D; Villarreal-Garza C; Michel RM; Astorga-Ramos AM; Martínez-Barrera L; de la Garza J
    J Thorac Oncol; 2009 Jul; 4(7):845-52. PubMed ID: 19487963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination chemotherapy with paclitaxel and gemcitabine followed by concurrent chemoradiotherapy in non-operable localized non-small cell lung cancer. A hellenic cooperative oncology group (HeCOG) phase II study.
    Kosmidis P; Fountzilas G; Baka S; Samantas E; Dimopoulos AM; Gogas H; Skarlos D; Papacostas P; Boukovinas J; Bakogiannis Ch; Pantelakos P; Athanasiou H; Misailidou D; Tsekeris P; Pavlidis N
    Anticancer Res; 2007; 27(6C):4391-5. PubMed ID: 18214050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Final overall results of a study with a novel triplet induction chemotherapy regimen (PACCAGE) followed by consolidation radiotherapy in locally advanced inoperable non-small cell lung cancer (NSCLC).
    Schallier D; Bral S; Ilsen B; Neyns B; Fontaine C; Decoster L; De Mey J; Meysman M; De Grève J
    J Thorac Oncol; 2009 Jun; 4(6):728-35. PubMed ID: 19404217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of paclitaxel and carboplatin in combined-modality therapy for locally advanced non-small cell lung cancer.
    Belani CP
    Semin Oncol; 1999 Feb; 26(1 Suppl 2):44-54. PubMed ID: 10190783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporating novel agents with gemcitabine-based treatment of NSCLC.
    Treat J
    Lung Cancer; 2005 Oct; 50 Suppl 1():S8-9. PubMed ID: 16291433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
    Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.
    Choy H; Jain AK; Moughan J; Curran W; Whipple G; Demas WF; Ettinger DS
    J Thorac Oncol; 2009 Jan; 4(1):80-6. PubMed ID: 19096311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemoradiotherapy with gemcitabine: potential applications.
    Choy H
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):20-5. PubMed ID: 10960941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gemcitabine and radiation therapy in non-small cell lung cancer: state of the art.
    Mornex F; Girard N
    Ann Oncol; 2006 Dec; 17(12):1743-7. PubMed ID: 16766586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gemcitabine/cisplatin as induction therapy for stage IIIA N2 non-small-cell lung cancer.
    Scagliotti GV
    Oncology (Williston Park); 2000 Jul; 14(7 Suppl 4):15-9. PubMed ID: 10960940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gemcitabine shows promise as combination agent in NSCLC.
    Oncology (Williston Park); 1996 Sep; 10(9):1311. PubMed ID: 9052981
    [No Abstract]   [Full Text] [Related]  

  • 19. The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
    Herbst RS; Khuri FR; Lu C; Liu DD; Fossella FV; Glisson BS; Pisters KM; Shin DM; Papadimitrakopoulou VA; Kurie JM; Blumenschein G; Kies MS; Zinner R; Jung MS; Lu R; Lee JJ; Munden RF; Hong WK; Lee JS
    Cancer; 2002 Jul; 95(2):340-53. PubMed ID: 12124835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction chemotherapy followed by concomitant chemoradiotherapy for non-small cell lung cancer.
    Vokes EE
    Oncologist; 2001; 6 Suppl 1():25-7. PubMed ID: 11182002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.